PingBack from http://articles.icmcc.org/2009/03/11/health-affairs-event-and-special-issue-on-health-it/

I attended the event and found it very useful to take a step back and review the big picture. Perhaps this was Carol Diamond was alluding too, but I didn't see nearly enough emphasis on rigorous research and evaluation of HIT. The hype and expectations seem to far outweigh discussions on testing (although I think it was Mark Smith who said we have to get this right).

On another note, HIT innovation overseas, especially in developing countries is far ahead of anything in the US and I am wondering when and if these two worlds will collide. There are a wide range of experiments and models taking place overseas, some of which will fail. The failure aspect as well as the innovation is something we could learn from. It would be great to see players from these two different areas sit in a room and exchange ideas.

Peter,

While I agree with most of your points, do find your last paragraph to be a bit of grandstanding and not entirely accurate.  

My own research points to the folks at Children's Hospital Informatics Program (CHIP) in Boston as the real thought-leaders in this drive to put consumer control of health data at the forefront. They did after all coin the term PCHRI.

Thankfully, MS, Google and Dossia have taken up this basic precept and with your far larger marketing clout, can make an impact in the market.

Keep up the good work, it's a long journey we are on.

After many long months of discussion and debate , the first draft of Meaningful Use has come out. I’m